Global Pulmonary Drug Delivery Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 157
Published Date: 02 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Pulmonary Drug Delivery Devices market size was valued at USD 2917.7 million in 2023 and is forecast to a readjusted size of USD 3844.5 million by 2030 with a CAGR of 4.0% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pulmonary Drug Delivery Devices industry chain, the market status of Asthma (Dry Powder Inhaler, Metered Dose Inhaler), COPD (Dry Powder Inhaler, Metered Dose Inhaler), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pulmonary Drug Delivery Devices.
Regionally, the report analyzes the Pulmonary Drug Delivery Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pulmonary Drug Delivery Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pulmonary Drug Delivery Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pulmonary Drug Delivery Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Dry Powder Inhaler, Metered Dose Inhaler).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pulmonary Drug Delivery Devices market.
Regional Analysis: The report involves examining the Pulmonary Drug Delivery Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pulmonary Drug Delivery Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pulmonary Drug Delivery Devices:
Company Analysis: Report covers individual Pulmonary Drug Delivery Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pulmonary Drug Delivery Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Asthma, COPD).
Technology Analysis: Report covers specific technologies relevant to Pulmonary Drug Delivery Devices. It assesses the current state, advancements, and potential future developments in Pulmonary Drug Delivery Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pulmonary Drug Delivery Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pulmonary Drug Delivery Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Market segment by Application
Asthma
COPD
Cystic Fibrosis
Other
Major players covered
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Devices, with price, sales, revenue and global market share of Pulmonary Drug Delivery Devices from 2019 to 2024.
Chapter 3, the Pulmonary Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pulmonary Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Drug Delivery Devices.
Chapter 14 and 15, to describe Pulmonary Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pulmonary Drug Delivery Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Dry Powder Inhaler
1.3.3 Metered Dose Inhaler
1.3.4 Nebulizer
1.4 Market Analysis by Application
1.4.1 Overview: Global Pulmonary Drug Delivery Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Asthma
1.4.3 COPD
1.4.4 Cystic Fibrosis
1.4.5 Other
1.5 Global Pulmonary Drug Delivery Devices Market Size & Forecast
1.5.1 Global Pulmonary Drug Delivery Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pulmonary Drug Delivery Devices Sales Quantity (2019-2030)
1.5.3 Global Pulmonary Drug Delivery Devices Average Price (2019-2030)
2.1 Boehringer Ingelheim GmbH
2.1.1 Boehringer Ingelheim GmbH Details
2.1.2 Boehringer Ingelheim GmbH Major Business
2.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
2.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Boehringer Ingelheim GmbH Recent Developments/Updates
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Pulmonary Drug Delivery Devices Product and Services
2.2.4 Novartis AG Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis AG Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
2.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Pulmonary Drug Delivery Devices Product and Services
2.4.4 AstraZeneca Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AstraZeneca Recent Developments/Updates
2.5 Teva Pharmaceutical Industries
2.5.1 Teva Pharmaceutical Industries Details
2.5.2 Teva Pharmaceutical Industries Major Business
2.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
2.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Pulmonary Drug Delivery Devices Product and Services
2.6.4 Merck Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Merck Recent Developments/Updates
2.7 MannKind
2.7.1 MannKind Details
2.7.2 MannKind Major Business
2.7.3 MannKind Pulmonary Drug Delivery Devices Product and Services
2.7.4 MannKind Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 MannKind Recent Developments/Updates
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
2.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers Squibb Recent Developments/Updates
2.9 Mylan N.V
2.9.1 Mylan N.V Details
2.9.2 Mylan N.V Major Business
2.9.3 Mylan N.V Pulmonary Drug Delivery Devices Product and Services
2.9.4 Mylan N.V Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mylan N.V Recent Developments/Updates
2.10 Omron Corp
2.10.1 Omron Corp Details
2.10.2 Omron Corp Major Business
2.10.3 Omron Corp Pulmonary Drug Delivery Devices Product and Services
2.10.4 Omron Corp Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Omron Corp Recent Developments/Updates
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
2.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 F. Hoffmann-La Roche Recent Developments/Updates
2.12 3M Healthcare
2.12.1 3M Healthcare Details
2.12.2 3M Healthcare Major Business
2.12.3 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
2.12.4 3M Healthcare Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 3M Healthcare Recent Developments/Updates
2.13 Sunovion Pharmaceuticals
2.13.1 Sunovion Pharmaceuticals Details
2.13.2 Sunovion Pharmaceuticals Major Business
2.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
2.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sunovion Pharmaceuticals Recent Developments/Updates
2.14 Koninklijke Philips N.V
2.14.1 Koninklijke Philips N.V Details
2.14.2 Koninklijke Philips N.V Major Business
2.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
2.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Koninklijke Philips N.V Recent Developments/Updates
2.15 Gerresheimer AG
2.15.1 Gerresheimer AG Details
2.15.2 Gerresheimer AG Major Business
2.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
2.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Gerresheimer AG Recent Developments/Updates
2.16 Bespak
2.16.1 Bespak Details
2.16.2 Bespak Major Business
2.16.3 Bespak Pulmonary Drug Delivery Devices Product and Services
2.16.4 Bespak Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Bespak Recent Developments/Updates
2.17 AptarGroup
2.17.1 AptarGroup Details
2.17.2 AptarGroup Major Business
2.17.3 AptarGroup Pulmonary Drug Delivery Devices Product and Services
2.17.4 AptarGroup Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 AptarGroup Recent Developments/Updates
2.18 SHL Group
2.18.1 SHL Group Details
2.18.2 SHL Group Major Business
2.18.3 SHL Group Pulmonary Drug Delivery Devices Product and Services
2.18.4 SHL Group Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 SHL Group Recent Developments/Updates
2.19 Nypro Healthcare
2.19.1 Nypro Healthcare Details
2.19.2 Nypro Healthcare Major Business
2.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
2.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Nypro Healthcare Recent Developments/Updates
2.20 Hovione
2.20.1 Hovione Details
2.20.2 Hovione Major Business
2.20.3 Hovione Pulmonary Drug Delivery Devices Product and Services
2.20.4 Hovione Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Hovione Recent Developments/Updates
2.21 Chiesi Farmaceutici S.P.A
2.21.1 Chiesi Farmaceutici S.P.A Details
2.21.2 Chiesi Farmaceutici S.P.A Major Business
2.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
2.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Chiesi Farmaceutici S.P.A Recent Developments/Updates
3.1 Global Pulmonary Drug Delivery Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2019-2024)
3.3 Global Pulmonary Drug Delivery Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pulmonary Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pulmonary Drug Delivery Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Pulmonary Drug Delivery Devices Manufacturer Market Share in 2023
3.5 Pulmonary Drug Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Pulmonary Drug Delivery Devices Market: Region Footprint
3.5.2 Pulmonary Drug Delivery Devices Market: Company Product Type Footprint
3.5.3 Pulmonary Drug Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Pulmonary Drug Delivery Devices Market Size by Region
4.1.1 Global Pulmonary Drug Delivery Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Pulmonary Drug Delivery Devices Consumption Value by Region (2019-2030)
4.1.3 Global Pulmonary Drug Delivery Devices Average Price by Region (2019-2030)
4.2 North America Pulmonary Drug Delivery Devices Consumption Value (2019-2030)
4.3 Europe Pulmonary Drug Delivery Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Pulmonary Drug Delivery Devices Consumption Value (2019-2030)
4.5 South America Pulmonary Drug Delivery Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Pulmonary Drug Delivery Devices Consumption Value (2019-2030)
5.1 Global Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2030)
5.2 Global Pulmonary Drug Delivery Devices Consumption Value by Type (2019-2030)
5.3 Global Pulmonary Drug Delivery Devices Average Price by Type (2019-2030)
6.1 Global Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2030)
6.2 Global Pulmonary Drug Delivery Devices Consumption Value by Application (2019-2030)
6.3 Global Pulmonary Drug Delivery Devices Average Price by Application (2019-2030)
7.1 North America Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2030)
7.2 North America Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2030)
7.3 North America Pulmonary Drug Delivery Devices Market Size by Country
7.3.1 North America Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2030)
8.2 Europe Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2030)
8.3 Europe Pulmonary Drug Delivery Devices Market Size by Country
8.3.1 Europe Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pulmonary Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pulmonary Drug Delivery Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2030)
10.2 South America Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2030)
10.3 South America Pulmonary Drug Delivery Devices Market Size by Country
10.3.1 South America Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pulmonary Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Pulmonary Drug Delivery Devices Market Drivers
12.2 Pulmonary Drug Delivery Devices Market Restraints
12.3 Pulmonary Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Pulmonary Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pulmonary Drug Delivery Devices
13.3 Pulmonary Drug Delivery Devices Production Process
13.4 Pulmonary Drug Delivery Devices Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pulmonary Drug Delivery Devices Typical Distributors
14.3 Pulmonary Drug Delivery Devices Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pulmonary Drug Delivery Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pulmonary Drug Delivery Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim GmbH Major Business
Table 5. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
Table 6. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 8. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 9. Novartis AG Major Business
Table 10. Novartis AG Pulmonary Drug Delivery Devices Product and Services
Table 11. Novartis AG Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis AG Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
Table 16. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Pulmonary Drug Delivery Devices Product and Services
Table 21. AstraZeneca Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. AstraZeneca Recent Developments/Updates
Table 23. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Major Business
Table 25. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
Table 26. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Teva Pharmaceutical Industries Recent Developments/Updates
Table 28. Merck Basic Information, Manufacturing Base and Competitors
Table 29. Merck Major Business
Table 30. Merck Pulmonary Drug Delivery Devices Product and Services
Table 31. Merck Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Merck Recent Developments/Updates
Table 33. MannKind Basic Information, Manufacturing Base and Competitors
Table 34. MannKind Major Business
Table 35. MannKind Pulmonary Drug Delivery Devices Product and Services
Table 36. MannKind Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. MannKind Recent Developments/Updates
Table 38. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb Major Business
Table 40. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
Table 41. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers Squibb Recent Developments/Updates
Table 43. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 44. Mylan N.V Major Business
Table 45. Mylan N.V Pulmonary Drug Delivery Devices Product and Services
Table 46. Mylan N.V Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Mylan N.V Recent Developments/Updates
Table 48. Omron Corp Basic Information, Manufacturing Base and Competitors
Table 49. Omron Corp Major Business
Table 50. Omron Corp Pulmonary Drug Delivery Devices Product and Services
Table 51. Omron Corp Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Omron Corp Recent Developments/Updates
Table 53. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 54. F. Hoffmann-La Roche Major Business
Table 55. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
Table 56. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. F. Hoffmann-La Roche Recent Developments/Updates
Table 58. 3M Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. 3M Healthcare Major Business
Table 60. 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 61. 3M Healthcare Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. 3M Healthcare Recent Developments/Updates
Table 63. Sunovion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Sunovion Pharmaceuticals Major Business
Table 65. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
Table 66. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sunovion Pharmaceuticals Recent Developments/Updates
Table 68. Koninklijke Philips N.V Basic Information, Manufacturing Base and Competitors
Table 69. Koninklijke Philips N.V Major Business
Table 70. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
Table 71. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Koninklijke Philips N.V Recent Developments/Updates
Table 73. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 74. Gerresheimer AG Major Business
Table 75. Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
Table 76. Gerresheimer AG Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Gerresheimer AG Recent Developments/Updates
Table 78. Bespak Basic Information, Manufacturing Base and Competitors
Table 79. Bespak Major Business
Table 80. Bespak Pulmonary Drug Delivery Devices Product and Services
Table 81. Bespak Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Bespak Recent Developments/Updates
Table 83. AptarGroup Basic Information, Manufacturing Base and Competitors
Table 84. AptarGroup Major Business
Table 85. AptarGroup Pulmonary Drug Delivery Devices Product and Services
Table 86. AptarGroup Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. AptarGroup Recent Developments/Updates
Table 88. SHL Group Basic Information, Manufacturing Base and Competitors
Table 89. SHL Group Major Business
Table 90. SHL Group Pulmonary Drug Delivery Devices Product and Services
Table 91. SHL Group Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. SHL Group Recent Developments/Updates
Table 93. Nypro Healthcare Basic Information, Manufacturing Base and Competitors
Table 94. Nypro Healthcare Major Business
Table 95. Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 96. Nypro Healthcare Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Nypro Healthcare Recent Developments/Updates
Table 98. Hovione Basic Information, Manufacturing Base and Competitors
Table 99. Hovione Major Business
Table 100. Hovione Pulmonary Drug Delivery Devices Product and Services
Table 101. Hovione Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Hovione Recent Developments/Updates
Table 103. Chiesi Farmaceutici S.P.A Basic Information, Manufacturing Base and Competitors
Table 104. Chiesi Farmaceutici S.P.A Major Business
Table 105. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
Table 106. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Chiesi Farmaceutici S.P.A Recent Developments/Updates
Table 108. Global Pulmonary Drug Delivery Devices Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 109. Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2019-2024) & (USD Million)
Table 110. Global Pulmonary Drug Delivery Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 111. Market Position of Manufacturers in Pulmonary Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 112. Head Office and Pulmonary Drug Delivery Devices Production Site of Key Manufacturer
Table 113. Pulmonary Drug Delivery Devices Market: Company Product Type Footprint
Table 114. Pulmonary Drug Delivery Devices Market: Company Product Application Footprint
Table 115. Pulmonary Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 116. Pulmonary Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Pulmonary Drug Delivery Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 118. Global Pulmonary Drug Delivery Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 119. Global Pulmonary Drug Delivery Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 120. Global Pulmonary Drug Delivery Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 121. Global Pulmonary Drug Delivery Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 122. Global Pulmonary Drug Delivery Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 123. Global Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 124. Global Pulmonary Drug Delivery Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 125. Global Pulmonary Drug Delivery Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Global Pulmonary Drug Delivery Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Global Pulmonary Drug Delivery Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 128. Global Pulmonary Drug Delivery Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 129. Global Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Global Pulmonary Drug Delivery Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Global Pulmonary Drug Delivery Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 132. Global Pulmonary Drug Delivery Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 133. Global Pulmonary Drug Delivery Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 134. Global Pulmonary Drug Delivery Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 135. North America Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 136. North America Pulmonary Drug Delivery Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 137. North America Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 138. North America Pulmonary Drug Delivery Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 139. North America Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 140. North America Pulmonary Drug Delivery Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 141. North America Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 142. North America Pulmonary Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Europe Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 144. Europe Pulmonary Drug Delivery Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 145. Europe Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 146. Europe Pulmonary Drug Delivery Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 147. Europe Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 148. Europe Pulmonary Drug Delivery Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 149. Europe Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 150. Europe Pulmonary Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 151. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 152. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 153. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 154. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 155. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 156. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 157. Asia-Pacific Pulmonary Drug Delivery Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 158. Asia-Pacific Pulmonary Drug Delivery Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 159. South America Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 160. South America Pulmonary Drug Delivery Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 161. South America Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 162. South America Pulmonary Drug Delivery Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 163. South America Pulmonary Drug Delivery Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 164. South America Pulmonary Drug Delivery Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 165. South America Pulmonary Drug Delivery Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 166. South America Pulmonary Drug Delivery Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 167. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 168. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 169. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 170. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 171. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 172. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 173. Middle East & Africa Pulmonary Drug Delivery Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 174. Middle East & Africa Pulmonary Drug Delivery Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 175. Pulmonary Drug Delivery Devices Raw Material
Table 176. Key Manufacturers of Pulmonary Drug Delivery Devices Raw Materials
Table 177. Pulmonary Drug Delivery Devices Typical Distributors
Table 178. Pulmonary Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Pulmonary Drug Delivery Devices Picture
Figure 2. Global Pulmonary Drug Delivery Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pulmonary Drug Delivery Devices Consumption Value Market Share by Type in 2023
Figure 4. Dry Powder Inhaler Examples
Figure 5. Metered Dose Inhaler Examples
Figure 6. Nebulizer Examples
Figure 7. Global Pulmonary Drug Delivery Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Pulmonary Drug Delivery Devices Consumption Value Market Share by Application in 2023
Figure 9. Asthma Examples
Figure 10. COPD Examples
Figure 11. Cystic Fibrosis Examples
Figure 12. Other Examples
Figure 13. Global Pulmonary Drug Delivery Devices Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Pulmonary Drug Delivery Devices Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Pulmonary Drug Delivery Devices Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Pulmonary Drug Delivery Devices Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Pulmonary Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Pulmonary Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Pulmonary Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Pulmonary Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Pulmonary Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Pulmonary Drug Delivery Devices Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Pulmonary Drug Delivery Devices Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Pulmonary Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Pulmonary Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Pulmonary Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Pulmonary Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Pulmonary Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Pulmonary Drug Delivery Devices Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Pulmonary Drug Delivery Devices Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Pulmonary Drug Delivery Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Pulmonary Drug Delivery Devices Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Pulmonary Drug Delivery Devices Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Pulmonary Drug Delivery Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Pulmonary Drug Delivery Devices Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Pulmonary Drug Delivery Devices Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Pulmonary Drug Delivery Devices Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Pulmonary Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Pulmonary Drug Delivery Devices Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Pulmonary Drug Delivery Devices Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Pulmonary Drug Delivery Devices Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Pulmonary Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Pulmonary Drug Delivery Devices Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Pulmonary Drug Delivery Devices Consumption Value Market Share by Region (2019-2030)
Figure 55. China Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Pulmonary Drug Delivery Devices Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Pulmonary Drug Delivery Devices Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Pulmonary Drug Delivery Devices Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Pulmonary Drug Delivery Devices Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Pulmonary Drug Delivery Devices Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Pulmonary Drug Delivery Devices Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Pulmonary Drug Delivery Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Pulmonary Drug Delivery Devices Market Drivers
Figure 76. Pulmonary Drug Delivery Devices Market Restraints
Figure 77. Pulmonary Drug Delivery Devices Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices in 2023
Figure 80. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
Figure 81. Pulmonary Drug Delivery Devices Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Boehringer Ingelheim GmbH Novartis AG GlaxoSmithKline AstraZeneca Teva Pharmaceutical Industries Merck MannKind Bristol-Myers Squibb Mylan N.V Omron Corp F. Hoffmann-La Roche 3M Healthcare Sunovion Pharmaceuticals Koninklijke Philips N.V Gerresheimer AG Bespak AptarGroup SHL Group Nypro Healthcare Hovione Chiesi Farmaceutici S.P.A
Related Reports
19 Feb 2021
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
